Also listed on JMD Pharma Creativity, LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Dec 27, 2042 · High confidence
20-year base term ends Dec 27, 2042
Held by Atai Therapeutics Inc.
Filed Dec 27, 2022 as application 18/146,785 · Granted Nov 28, 2023
Base term, 20 years from filing
Today
2022
2042
Clock starts
Dec 27, 2022
Dec 27, 2022
Term ends
Dec 27, 2042
Dec 27, 2042
Granted
Nov 28, 2023
Nov 28, 2023
base term
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 27, 2022, when this application, 18/146,785, was filed | Dec 27, 2042 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 27, 2042 | High confidence |
This family
| US 11,827,580 | this patent Dec 2042 | Dec 2042 |
| US 12,344,570 | In force Dec 2042 | Dec 2042 |
| Application 19/215,023 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 12, 2023 Reel 63301, frame 560 | Perni, Robert B. | JMD Pharma Creativity, LLC | Assignment of Assignor's Interest |
| Apr 25, 2023 Reel 63430, frame 860 | Short, Glenn; Khan, Tanweer A. | Atai Life Sciences AG | Assignment of Assignor's Interest |
| Jul 27, 2023 Reel 64405, frame 393 | JMD Pharma Creativity, LLC | Atai Life Sciences US, Inc. | Assignment of Assignor's Interest |
| Jul 31, 2023 Reel 64441, frame 247 | Atai Life Sciences US, Inc. | Atai Life Sciences AG | Assignment of Assignor's Interest |
| Jan 2, 2024 Reel 65992, frame 782 | Entheogenix Biosciences, Inc. | Atai Therapeutics Inc. | Assignment of Assignor's Interest |
| Jan 2, 2024 Reel 65992, frame 310 | Atai Life Sciences AG | Entheogenix Biosciences, Inc. | Assignment of Assignor's Interest |
| Feb 12, 2025 Reel 70202, frame 400 | Entheogenix Biosciences, Inc. | Atai Therapeutics, Inc. | Corrective Assignment to Correct the the Name of the Assignee Previously Recorded at Reel: 65992 Frame: 782. Assignor(S) Hereby Confirms the Assignment. |
| Feb 12, 2025 Reel 70202, frame 414 | Atai Life Sciences AG | Entheogenix Biosciences, Inc. | Corrective Assignment to Correct the Assignment Previously Recorded Under Reel and Frame 065992/0310 to Correct the Assignor from Atai Life Sciences Ag to Atai Life Sciences Ag. Previously Recorded on Reel 65992 Frame 310. Assignor(S) Hereby Confirms the Assignment. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Dec 2042
Term ends Dec 27, 2042. Maintenance fees still fall due before then
Citations
10
later US patents cite this one
That is top 10% of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.